AQUINOX PHARMACEUTICALS, INC (35) | License Agreements (3)
Recent Contracts
-
Amendment No. 2 to Exclusive Start-Up License Agreement, dated December 15, 2021, by and between the University of Washington and Neoleukin Therapeutics, Inc
(Filed With SEC on March 1, 2022)
-
Amendment No. 1 to Exclusive Start-Up License Agreemen
(Filed With SEC on March 25, 2021)
-
Exclusive Start-Up License Agreement, dated July 8, 2019, by and between the University of Washington and Neoleukin Therapeutics, Inc
(Filed With SEC on August 12, 2019)
